查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1413824

病理學人工智慧市場：按組件、神經網路、應用程式和最終用戶分類 - 2024-2030 年全球預測

AI in Pathology Market by Component (Hardware, Software), Neural Network (Convolutional neural networks (CNNs), Generative adversarial networks (GANs), Recurrent neural networks (RNNs)), Application, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

病理學人工智慧市場規模預估2023年為2,901萬美元，預估2024年將達3,336萬美元，2030年將達7,875萬美元，複合年成長率為15.33%。

病理學人工智慧的全球市場

主要市場統計
基準年[2023] 2901萬美元
預測年份 [2024] 3336萬美元
預測年份 [2030] 7875萬美元
複合年成長率（%） 15.33%
病理學人工智慧市場-IMG1

病理學中的人工智慧 (AI) 透過整合先進的計算技術、機器學習演算法和影像分析工具來自動化診斷過程的各個方面，從而提高病理診斷的速度、準確性和效率。準確快速診斷的新興市場的開拓、需要及時診斷的癌症等慢性病盛行率的上升以及數位病理基礎設施的持續發展都有力地促進了市場的成長。此外，政府也持續投資研發活動和支持性舉措，旨在加速醫療數位化。此外，對於許多醫療機構來說，開發和整合基於人工智慧的病理學解決方案可能成本高昂。此外，使用雲端基礎的解決方案共用患者資料會引發對資料外洩和未授權存取敏感資訊的擔憂。除此之外，機器學習技術和人工智慧能力的快速進步正在為市場成長創造潛在機會。此外，可以利用區塊鏈等新技術來確保患者資料的安全儲存和傳輸。

區域洞察

在美洲，人工智慧主導的病理解決方案正在進行大量投資，以推動數位診斷。食品藥物管理局也開始批准基於人工智慧的醫療設備，這表明這些技術正在獲得認可。歐盟委員會的計劃為專注於健康和護理數位轉型的計劃提供了大量資金。改善歐盟地區的醫療基礎設施為基於人工智慧的病理解決方案提供了獨特的機會。在亞太地區，領先的公司正在大力投資數位診斷。政府措施也支持該領域的研究和開發，產生了大量專利和研究出版物。此外，亞太地區新興經濟體醫療保健基礎設施的發展正在推動數位醫療保健解決方案的採用。

FPNV定位矩陣

FPNV定位矩陣對於評估病理市場的AI至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一個綜合工具，可以對病理學市場人工智慧供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-病理學AI市場的市場規模和預測是多少？

2-在病理學市場的人工智慧預測期內，有哪些產品、細分市場、應用程式和領域需要考慮投資？

3-病理學AI市場的技術趨勢和法律規範是什麼？

4-病理學市場AI主要廠商的市場佔有率是多少？

5-進入病理AI市場有哪些合適的型態與策略手段？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地病理學數位化進展
      • 隨著慢性病變得更加普遍，對遠距病理學的需求也隨之增加。
    • 抑制因素
      • 病理學人工智慧相關的高成本
    • 機會
      • AI技術在病理學領域的進展
      • 對個體化和客製化醫療保健的需求不斷成長
    • 任務
      • 資料隱私問題
  • 市場區隔分析
    • 組件：廣泛的病理學軟體應用程式，可實現無縫工作流程和高效資料管理
    • 神經網路：診斷準確性和效率推動生成對抗網路的更多採用
    • 應用實例：廣泛利用AI在病理領域進行疾病診斷，促進疾病早期發現
    • 最終用戶：在製藥和生物技術公司中擴展病理學人工智慧以發現潛在的治療方法
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章病理學人工智慧市場：按組成部分

  • 硬體
  • 軟體

第 7 章神經網路病理學人工智慧市場

  • 卷積類神經網路（CNN）
  • 生成對抗網路（GAN）
  • 循環神經網路 (RNN)

第8章病理學人工智慧市場：按應用分類

  • 臨床工作流程
  • 疾病診斷與預後
  • 藥物研發
  • 培訓和教育

第 9 章病理學人工智慧市場：按最終用戶分類

  • 學術研究所
  • 醫院
  • 製藥和生物技術公司

第 10 章：美洲病理學人工智慧市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區病理學人工智慧市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章：歐洲、中東和非洲病理學人工智慧市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析
    • 合約、合作和夥伴關係
    • 新產品發布和功能增強

第14章競爭產品組合

  • 主要公司簡介
    • aetherAI
    • Aiforia Technologies Oyj
    • Akoya Biosciences, Inc.
    • Deep Bio, Inc.
    • Evident Corporation
    • F. Hoffmann-La Roche Ltd.
    • Ibex Medical Analytics Ltd.
    • Indica Labs, Inc.
    • Inspirata, Inc.
    • LUMEA, Inc.
    • MindPeak GmbH
    • Nucleai Inc.
    • OptraSCAN Inc.
    • Paige.AI, Inc.
    • PathAI, Inc.
    • Proscia Inc.
    • Techcyte, Inc.
    • Tempus Labs, Inc.
    • Tribun Health
    • Visikol, Inc. by CELLINK
    • Visiopharm A/S
  • 主要產品系列

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-1730A405FA4C

[183 Pages Report] The AI in Pathology Market size was estimated at USD 29.01 million in 2023 and expected to reach USD 33.36 million in 2024, at a CAGR 15.33% to reach USD 78.75 million by 2030.

Global AI in Pathology Market

KEY MARKET STATISTICS
Base Year [2023] USD 29.01 million
Estimated Year [2024] USD 33.36 million
Forecast Year [2030] USD 78.75 million
CAGR (%) 15.33%
AI in Pathology Market - IMG1

Artificial intelligence (AI) in pathology integrates advanced computational techniques, machine learning algorithms, and image analysis tools to improve pathological diagnoses' speed, accuracy, and efficiency by automating various aspects of the diagnostic process. Increasing demand for accurate and quick diagnostics, the rising chronic diseases prevalence such as cancer that require timely diagnosis, and continuous developments in digital pathology infrastructure strongly contribute to the growth of the market. In addition, ongoing investments in research and development activities and supportive government initiatives aimed at promoting healthcare digitization. Furthermore, the development and integration of AI-based solutions in pathology can be an expensive affair for many healthcare organizations. Also, the usage of cloud-based solutions for sharing patient data raises concerns about data breaches and unauthorized access to sensitive information. Apart from this, rapid advancements in machine learning techniques & artificial intelligence capabilities create a potential opportunity for market growth. Additionally, emerging technologies such as blockchain can be leveraged to ensure secure storage and transfer of patient data.

Regional Insights

In the Americas, significant investments have been made in AI-driven pathology solutions to advance digital diagnostics. The Food and Drug Administration has also started approving AI-based medical devices, demonstrating an increasing acceptance of such technologies. The European Commission's program has provided significant funding for projects focusing on digital transformation in health and care. Improved healthcare infrastructure in the EU region presents a unique opportunity for AI-based pathology solutions. In the APAC region, major players have made significant investments in digital diagnostics. Government initiatives have also supported R&D in this sector, leading to numerous patents and research publications. Also, the development of healthcare infrastructure in the developing economies of the APAC region endorses the adoption of digital healthcare solutions.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the AI in Pathology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the AI in Pathology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the AI in Pathology Market, highlighting leading vendors and their innovative profiles. These include aetherAI, Aiforia Technologies Oyj, Akoya Biosciences, Inc., Deep Bio, Inc., Evident Corporation, F. Hoffmann-La Roche Ltd., Ibex Medical Analytics Ltd., Indica Labs, Inc., Inspirata, Inc., LUMEA, Inc., MindPeak GmbH, Nucleai Inc., OptraSCAN Inc., Paige.AI, Inc., PathAI, Inc., Proscia Inc., Techcyte, Inc., Tempus Labs, Inc., Tribun Health, Visikol, Inc. by CELLINK, and Visiopharm A/S.

Market Segmentation & Coverage

This research report categorizes the AI in Pathology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Component
    • Hardware
    • Software
  • Neural Network
    • Convolutional neural networks (CNNs)
    • Generative adversarial networks (GANs)
    • Recurrent neural networks (RNNs)
  • Application
    • Clinical Workflow
    • Disease Diagnosis & Prognosis
    • Drug Discovery
    • Training & Education
  • End-User
    • Academic & Research Institutes
    • Hospitals
    • Pharmaceuticals & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the AI in Pathology Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the AI in Pathology Market?

3. What are the technology trends and regulatory frameworks in the AI in Pathology Market?

4. What is the market share of the leading vendors in the AI in Pathology Market?

5. Which modes and strategic moves are suitable for entering the AI in Pathology Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. AI in Pathology Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing digitalization of pathology worldwide
      • 5.1.1.2. Growing need for telepathology with the prevalence of chronic disease
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with AI in pathology
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in AI in pathology
      • 5.1.3.2. Rising demand for personalized and customized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with data privacy
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Extensive software applications in pathology for seamless workflows and efficient data management
    • 5.2.2. Neural Network: Increasing generative adversarial networks adoption due to diagnostic accuracy and efficiency
    • 5.2.3. Application: Wide utilization of AI in pathology for disease diagnosis to facilitate early detection of diseases
    • 5.2.4. End-User: Expansion of pathology AI in pharmaceuticals & biotechnology companies for discovering potential therapeutics
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. AI in Pathology Market, by Component

  • 6.1. Introduction
  • 6.2. Hardware
  • 6.3. Software

7. AI in Pathology Market, by Neural Network

  • 7.1. Introduction
  • 7.2. Convolutional neural networks (CNNs)
  • 7.3. Generative adversarial networks (GANs)
  • 7.4. Recurrent neural networks (RNNs)

8. AI in Pathology Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical Workflow
  • 8.3. Disease Diagnosis & Prognosis
  • 8.4. Drug Discovery
  • 8.5. Training & Education

9. AI in Pathology Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Hospitals
  • 9.4. Pharmaceuticals & Biotechnology Companies

10. Americas AI in Pathology Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific AI in Pathology Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa AI in Pathology Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. Agreement, Collaboration, & Partnership
      • 13.3.1.1. Microsoft Collab to Build World's Largest Pathology, Oncology Imaging AI
      • 13.3.1.2. Paige and Leica Biosystems Announce Expanded Partnership to Enhance Use of Image Management and Artificial Intelligence Technology in Global Digital Pathology Workflows
    • 13.3.2. New Product Launch & Enhancement
      • 13.3.2.1. PathAI Announces PathExplore, an AI-powered Pathology Panel to Unlock Untapped Insights from the Tumor Microenvironment

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. aetherAI
    • 14.1.2. Aiforia Technologies Oyj
    • 14.1.3. Akoya Biosciences, Inc.
    • 14.1.4. Deep Bio, Inc.
    • 14.1.5. Evident Corporation
    • 14.1.6. F. Hoffmann-La Roche Ltd.
    • 14.1.7. Ibex Medical Analytics Ltd.
    • 14.1.8. Indica Labs, Inc.
    • 14.1.9. Inspirata, Inc.
    • 14.1.10. LUMEA, Inc.
    • 14.1.11. MindPeak GmbH
    • 14.1.12. Nucleai Inc.
    • 14.1.13. OptraSCAN Inc.
    • 14.1.14. Paige.AI, Inc.
    • 14.1.15. PathAI, Inc.
    • 14.1.16. Proscia Inc.
    • 14.1.17. Techcyte, Inc.
    • 14.1.18. Tempus Labs, Inc.
    • 14.1.19. Tribun Health
    • 14.1.20. Visikol, Inc. by CELLINK
    • 14.1.21. Visiopharm A/S
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. AI IN PATHOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. AI IN PATHOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. AI IN PATHOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. AI IN PATHOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. AI IN PATHOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. AI IN PATHOLOGY MARKET DYNAMICS
  • FIGURE 7. AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 8. AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2023 VS 2030 (%)
  • FIGURE 10. AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. AI IN PATHOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. AI IN PATHOLOGY MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. AI IN PATHOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. AI IN PATHOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 6. AI IN PATHOLOGY MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. AI IN PATHOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 9. AI IN PATHOLOGY MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS (CNNS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. AI IN PATHOLOGY MARKET SIZE, BY GENERATIVE ADVERSARIAL NETWORKS (GANS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. AI IN PATHOLOGY MARKET SIZE, BY RECURRENT NEURAL NETWORKS (RNNS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. AI IN PATHOLOGY MARKET SIZE, BY CLINICAL WORKFLOW, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AI IN PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS & PROGNOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AI IN PATHOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AI IN PATHOLOGY MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. AI IN PATHOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AI IN PATHOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AI IN PATHOLOGY MARKET SIZE, BY PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. AI IN PATHOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 190. AI IN PATHOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. AI IN PATHOLOGY MARKET LICENSE & PRICING